Companies / Argentina
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Homegrown Drugmakers Win New Export Markets
November 2006 | FDI AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Drugmakers in Argentina are entering new export markets as far afield as Yemen and Singapore, helping to reduce reliance on traditional markets in Latin America. The region still accounted for 70% of the country's pharmaceutical exports in 2005, but foreign sales dipped to just ARS496mn (US$163mn) in the year. One reason for this downturn is that the country's rapidly appreciating currency has made Argentine products less attractive to buyers in neighbouring